Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an overview-Reference-Cited by-同舟云学术

Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an overview

Published:2014-05-08 Issue: Volume: Page:1-18
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opin. Drug Saf.

Author:

Semeraro Francesco,Morescalchi Francesco,Duse Sarah,Gambicorti Elena,Romano Mario R,Costagliola Ciro

Publisher

Informa Healthcare

Subject

Pharmacology (medical),General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14740338.2014.911284

Reference114 articles.

1. The biology of VEGF and its receptors

2. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: Therapeutic implications

3. Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiogenesis in Chronic Thromboembolic Pulmonary Hypertension: A Janus-Faced Player?;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-04

2. Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration;Journal of Translational Medicine;2023-02-21

3. Evaluation of cardiac parameters and other safety outcomes of brolucizumab treatment in patients with neovascular age‐related macular degeneration;Pharmacology Research & Perspectives;2022-03-18

4. Effect Modification by Indication to the Risks of Major Thromboembolic Adverse Events in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Treatment: A Population-Based Retrospective Cohort Study;BioDrugs;2022-03

5. Impact of retinal vein occlusion on cardiovascular events in elderly Japanese patients;Medicine;2021-12-30